Advertisement
Product › Details
CRISPR gene editing technology
Next higher product group | nucleic acid editing technology (DNA/RNA-editing technology) | |
Status | 2013-09-16 use/installation existent | |
Organisation | Harvard University | |
Original research | Harvard University | |
Record changed: 2024-02-15 |
Advertisement
More documents for CRISPR gene editing technology
- [1] CRISPR Therapeutics AG. (2/13/24). "Press Release: CRISPR Therapeutics Announces $280 Million Registered Direct Offering". Zug & Boston, MA....
- [2] Empyrean Neuroscience, Inc.. (10/18/22). "Press Release: Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform to Advance Pipeline of Neuroactive Compounds Targeting CNS Disorders". New York, NY & Cambridge....
- [3] CRISPR Therapeutics AG. (8/31/22). "Press Release: CRISPR Therapeutics to Participate in Upcoming Investor Conferences". Zug & Cambridge, MA....
- [4] Immatics N.V.. (6/7/22). "Press Release: Immatics and Editas Medicine Enter Strategic Research Collaboration and Licensing Agreement to Combine Gamma-Delta T Cell Adoptive Cell Therapies and Gene Editing for the Treatment of Cancer". Tübingen, Houston, T...
- [5] BRAIN Biotech AG. (5/30/22). "Press Release: Ongoing Dynamic Sales Development and Rising Profitability, 6M Reporting". Zwingenberg....
- [6] Mammoth Biosciences, Inc.. (1/10/22). "Press Release: Bayer and Mammoth Biosciences to Collaborate on Novel Gene Editing Technology". Berlin & Brisbane, CA....
- [7] CRISPR Therapeutics AG. (10/14/21). "Press Release: CRISPR Therapeutics Announces Transition of Chief Financial Officer". Zug & Cambridge, MA....
- [8] CRISPR Therapeutics AG. (5/6/21). "Press Release: CRISPR Therapeutics and Nkarta Announce Global Collaboration to Develop Gene-Edited Cell Therapies for Cancer". Zug, Cambridge, MA & South San Francisco, CA....
- [9] Twist Bioscience Corporation. (4/28/21). "Press Release: Twist Bioscience and Vivlion Partner to Generate gRNA Libraries for CRISPR Applications". South San Francisco, CA & Frankfurt am Main....
- [10] Cytosurge AG. (3/24/21). "Press Release: Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeks". Zürich....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top